Active Ingredient: FLECAINIDE
(Hérité de FLECAINE 100 mg) Case reports with QT prolongation with flecain, but it seems safe in patient with LQT3 syndrome due to SCN5A mutations : https://doi.org/10.1093/europace/euw439
https://doi.org/10.1002/phar.1403, https://doi.org/10.1016/j.ijcard.2006.07.124, https://doi.org/10.1016/j.jccase.2011.02.006